Deborah Farr, M.D. is a surgical oncologist who specializes in treating breast cancer. When Dr. Farr heard about Olivia Munn’s diagnosis, she immediately knew what tool gave her the lifesaving information that she needed. “The breast cancer risk assessment tool…
Tag: Breast Cancer
Breast Cancer Diagnoses Plummeted During First Year of Pandemic
There was a 15-20% decrease in newly diagnosed breast cancer cases reported to American College of Surgeons Commission on Cancer sites in 2020 compared to 2019.
¿La soja aumenta el riesgo de cáncer de mama?
Ha generado varios debates. ¿Hay alguna conexión entre la soja y el cáncer de mama? La soja contiene isoflavonas, que son los estrógenos vegetales. Se han relacionado los niveles altos de estrógeno con un mayor riesgo de cáncer de mama. Sin embargo, hay estudios que demuestran que los productos de soja no contienen niveles de estrógeno lo suficientemente altos como para aumentar las probabilidades de desarrollar cáncer de mama.
Researchers Perform Anatomical Dissection to Identify Sensory Nerves for Improved Cancer Treatment
Researchers from the London Health Sciences Centre use anatomical dissection to identify undocumented nerve pathways for the most diagnosed cancer worldwide.
Study Identifies Successful Methods to Recruit South Asian Women for Breast Cancer Research
Rutgers Health experts, conducting research during the COVID-19 pandemic, found that radio is an effective recruitment tool
Launch of a pioneering translational research programme in Europe
– The TRIP initiative establishes three new joint laboratories that bring together fundamental biomedical research and clinical research with the aim of accelerating the delivery of results to patients.
– TRIP will focus on emerging fields such as immuno-oncology, inflammation, and cellular senescence.
NCCN Updates Treatment Recommendations for Breast, Colorectal, Lung, and other Cancer Types Based on Emerging Evidence
Recent NCCN Guidelines updates—along with the supporting evidence—will be presented during the NCCN 2024 Annual Conference held in Orlando, Florida April 5-7, and simultaneously online. Visit NCCN.org/conference to learn more and register.
Study Underscores Social Factors of Low Breast Cancer Screening in the U.S.
To identify major social factors hindering breast cancer screening in U.S. women aged 40 and older, researchers focused on race/ethnicity, employment, education, food security, insurance status, housing and access to quality health care. Access to health care emerged as a statistically significant theme (61 percent) and insurance status was the most reported sub-categorical factor. Language was the third highest issue, highlighting its significance as an influential factor of screening behavior. Race/ethnicity, sex/gender and sexual orientation were additional factors reported.
National Breast Cancer Foundation Gives Grant to Help Breast Care Center Patients at Texas Tech Physicians of El Paso
In addition to assisting with access to care, such as transportation and general needs like groceries, the grant will allow the Breast Care Center to screen for mental and emotional distress using tablets. Currently, patients participate in an online distress screening survey that prompts questions about financial and psychosocial stressors in a patient’s life.
The Wistar Institute Announces New Caspar Wistar Fellow, Dr. Irene Bertolini
Wistar Institute is pleased to announce the recruitment of Irene Bertolini, Ph.D., to pursue research in breast and brain cancers.
Novel Drug Combination Shows Promise for Advanced HER2-Negative Breast Cancer
A novel three-drug combination achieved notable responses in patients with advanced HER2-negative breast cancer, according to new research directed by investigators from the Johns Hopkins Kimmel Cancer Center.
Would You Prefer a Mammogram, MRI, or Saliva on a Test Strip?
In JVSTB, researchers report successful results from a hand-held breast cancer screening device that can detect breast cancer biomarkers from a tiny sample of saliva.
Strongest contender in decades in fight against breast cancer
For decades, hormonal treatment of breast cancer has been going in one direction – blocking estrogen.
MD Anderson Research Highlights for February 7, 2024
The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention.
Re-excision rates after breast-conserving surgery pose ongoing challenges in the US: UTHealth Houston study unveils high reoperation rates and costs
Rates of re-excision after initial breast-conserving surgery in women with breast cancer remain high across the United States, leading to an increased cost of care and a higher risk of postoperative complications, according to new research from UTHealth Houston.
Director of Oncology Services Northern Region Named to New Jersey’s Only NCI-designated Comprehensive Cancer Center
George Raptis, MD, MBA, begins role at Rutgers Cancer Institute of New Jersey and RWJBarnabas Health as director of Oncology Services for the Northern Region of New Jersey.
Breast cancer test may make bad chemotherapy recommendations for Black patients
Test may underestimate the benefit of chemotherapy for Black women, especially those who are young
Breast cancer rates increasing among younger women
According to a study led by researchers at Washington University School of Medicine in St. Louis, diagnoses of breast cancer have increased steadily in women under age 50 over the past two decades, with steeper increases in more recent years.
New Research in JNCCN Suggests a Simple and Inexpensive Option for Reducing a Major Chemotherapy Side-Effect
New research in the November 2023 issue of JNCCN—Journal of the National Comprehensive Cancer Network suggests that breast cancer patients who have insufficient levels of vitamin D before starting paclitaxel treatment are more likely to experience peripheral neuropathy.
Teaming Up to Tackle Breast Cancer Disparities
The Miami Dolphins and AutoNation have teamed up to fund a $1-million, four-year Breast Cancer Research Foundation project at Sylvester Comprehensive Cancer Center to investigate critical health disparities that drive mortality among breast cancer patients.
Making Patients Whole
For Gladys Tsao-Wu, MD, and Jennifer Chan, MD, reconstruction is as much about helping patients recover emotionally as it is about physical restoration. For over a decade, the two surgeons have been a team, helping breast cancer survivors in New Mexico.
New NUS study provides insights into early breast cancer development in individuals with BRCA2 mutations
A pioneering study led by the Cancer Science Institute of Singapore (CSI Singapore) at the National University of Singapore and the University of Cambridge (UK) has uncovered vital insights into the distinct effects of BRCA2 mutations on breast tissue cells, shedding light on early breast cancer development in people with BRCA2 mutations.
New antibody could target breast cancers
An enzyme that may help some breast cancers spread can be stopped with an antibody created in the lab of Cold Spring Harbor Laboratory Professor Nicholas Tonks.
New Study Shows Insurance Coverage Disruptions Affect Key Cancer Screenings for U.S. Adults
A new study by researchers at the American Cancer Society shows that adults in the United States with prior insurance coverage disruptions are significantly less likely to receive guideline-concordant and past-year cancer screening, compared to people with continuous coverage.
Breast cancer survivors: New training to treat ‘chemo-brain’
A form of computerised attention and memory training can improve impaired attention and memory issues in women treated for breast cancer, University of Reading researchers have found
MEDSIR presents the results of three new studies at ESMO 2023: LUPER, focusing on lung cancer, and two translational studies of PHERGain in breast cancer
MEDSIR, a company specializing in the strategic design of independent clinical research, today presented the results of three new studies at the European Society for Medical Oncology (ESMO 2023).
Reliable Patient Education Materials on Breast Cancer Are Difficult to Access
Women with breast cancer must often make complex decisions about surgery and treatment options during an already stressful time in their lives, and many of these women may turn to the wide variety of materials available online. New research presented at the American College of Surgeons (ACS) Clinical Congress 2023 has found that reliable educational materials about breast surgery are not only difficult to assess but are also presented at much higher reading levels than recommended.
A Cancer Survival Calculator Is Being Developed Using Artificial Intelligence
Researchers have developed an artificial intelligence (AI)–based tool for estimating a newly diagnosed cancer patient’s chances for surviving long term, according to a study presented at the American College of Surgeons (ACS) Clinical Congress 2023.
Can Lifestyle Interventions Benefit Patients With Advanced Breast Cancer?
Can exercise, intermittent fasting and other lifestyle changes help patients with advanced breast cancer better tolerate side effects from treatment? A new $4-million NCI-funded study at Sylvester Comprehensive Cancer Center seeks to answer that question.
MD Anderson Research Highlights: ESMO 2023 Special Edition
This special edition features upcoming oral presentations by MD Anderson researchers at the 2023 European Society for Medical Oncology (ESMO) Congress focused on clinical advances across a variety of cancer types.
New online tool allows women to quickly assess their risk of breast and ovarian cancer
Do you know your risk for breast and ovarian cancer? How about steps you can take to reduce your chances of developing cancer or what a family history might mean for your risk of the disease?
Susan G. Komen® Conference Will Support People Living With Metastatic Breast Cancer
Susan G. Komen® will hold a Metastatic Breast Cancer Impact Series Conference in Philadelphia that will include sessions with leading experts, survivor stories, wellness guidance, and interactive Q&A, offering attendees valuable insights, inspiration, practical tips, and community support.
Inflammatory Breast Cancer: Know the Risks and Warning Signs of This Rare, Fast-Growing Cancer
Inflammatory breast cancer is a rare type of breast cancer. It only accounts for one to five percent of all breast cancer cases, but it’s important to know your risk and the warning signs, as this form of the disease is aggressive, fast-growing, and hard to detect early. For October, during Breast Cancer Awareness Month, the American Cancer Society is highlighting IBC to help women be aware of this invasive cancer.
MD Anderson launches collaborative initiative to reduce breast cancer disparities in Houston area
The University of Texas MD Anderson Cancer Center launches a community-wide health care initiative to reduce breast cancer disparities in the Houston area, particularly for Black women. Texas Health Equity Alliance for Breast Cancer (THEAL), seeks to lower the Black/white breast cancer mortality gap in Harris County by 15% over the next decade.
MD Anderson Research Highlights for October 4, 2023
The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These advances are made possible through seamless collaboration between MD Anderson’s world-leading clinicians and scientists, bringing discoveries from the lab to the clinic and back. Recent developments at MD Anderson include a computer game that helps breast cancer survivors improve symptoms of peripheral neuropathy, a publicly available single-cell atlas of CD19 chimeric antigen receptor (CAR) T cells, new targets for TP53-mutant acute myeloid leukemia (AML), a preclinical target for preventing chemobrain, a blood test to help identify patients at higher risk of developing pancreatic cancer, and genomic insights to predict the risk of outcomes in patients with bone cancer.
New robot could help diagnose breast cancer early
A device has been created that could carry out Clinical Breast Examinations (CBE).
Susan G. Komen® Analysis Shows Many Breast Cancer Patients Struggle To Afford Basic Needs: Housing, Transportation, Utilities
Lower income breast cancer patients often struggle to afford life’s necessities such as housing, transportation and utilities due to direct and incidental costs related to their treatment, according to a new analysis by Susan G. Komen®.
Shorter course of radiation therapy is safe for patients with early-stage breast cancer who have undergone mastectomy and reconstruction
Researchers at Dana-Farber Brigham Cancer Center have found that a shorter course of radiation therapy after mastectomy and breast reconstruction surgery provides the same protection against breast cancer recurrence and equivalent physical side-effects but substantially reduces life disruption and financial burden for patients.
Short-course radiation as effective as standard treatment for patients who opt for breast reconstruction after mastectomy
In a first-of-its-kind study, people with breast cancer who underwent implant-based breast reconstruction immediately following a mastectomy reported that getting fewer, higher doses of radiation was just as effective as standard radiation, did not increase side effects and saved them time and money.
With Regular Screening, More Women Survive Breast Cancer
To mark Breast Cancer Awareness Month, the American Cancer Society highlights its guidelines encouraging average-risk women to begin regular screening mammograms at age 45, with the option to begin screening as early as age 40.
Palex and Inbiomotion introduce pioneering test to aid oncologists in predicting recurrence and survival rates in breast cancer patients
Spain is the first country in the world to have this technology
• Results showing the clinical utility of the test were published in
Lancet Oncology and the Journal of National Cancer Institute
• The test is now available to oncologists and pathologists and will
benefit an estimated 24,000 patients each year in Spain
A New AI Model Has Been Developed to Improve Accuracy of Breast Cancer Tumor Removal
Researchers in the UNC School of Medicine have developed an AI model that can predict whether or not cancerous tissue has been fully removed from the body during breast cancer surgery.
Susan G. Komen® To Host MORE THAN PINK Walk in Dallas this Fall
Susan G. Komen®, the world’s leading breast cancer organization, today announced it will host a MORE THAN PINK Walk in Dallas on Saturday, Oct. 21, 2023. The events will raise critical funds that support breast cancer patients, advance research and provide patient navigation services to better serve those impacted by the disease.
Researchers at Case Western Reserve, University Hospitals to assess effectiveness of novel MRI method for breast cancer patients
Researchers at Case Western Reserve University
(CWRU) and University Hospitals (UH) will study whether a new magnetic resonance imaging exam can predict how chemotherapy’s effectiveness for a woman with breast cancer based on a single round of treatment.
Susan G. Komen® To Host MORE THAN PINK Walk in Arkansas This Fall
Susan G. Komen®, the world’s leading breast cancer organization, today announced it will host a MORE THAN PINK Walk in Arkansas this fall. The Northwest Arkansas MORE THAN PINK Walk will take place on Saturday, Oct. 7, 2023.
Mayo Clinic study reveals proton beam therapy may shorten breast cancer treatment
In a randomized trial, published in The Lancet Oncology, Mayo Clinic Comprehensive Cancer Center researchers uncover evidence supporting a shorter treatment time for breast cancer patients.
Living Beyond Breast Cancer Provides Expert Patient Perspectives during Breast Cancer Awareness Month
This fall, Living Beyond Breast cancer, the national patient information and support organization, is providing expert patient perspectives on patients living with breast cancer. Connect with members of the LBBC community to discuss living with breast cancer, racial equity in breast cancer health, and body image and reconstruction.
Study Unlocks New Insight about Breast Cancer Risk
A new study led by a researcher at New York Institute of Technology provides insight that could change how scientists and clinicians understand genetic predisposition to breast cancer, a condition that affects one in eight U.S. women in her lifetime.
Cancer screenings have saved the U.S. at least $6.5 trillion, study estimates
Americans have gotten at least 12 million more years of life to live because of preventive cancer screenings they’ve gotten the past 25 years, a new study estimates. That adds up to at least $6.5 trillion in added economic impact, because of scans and tests that look for early signs of breast, colon, cervical and lung cancer in adults at the highest risk.
Canadian researchers find radiation not necessary for patients with low-risk breast cancer
Researchers from McMaster University, BC Cancer, Hamilton Heath Sciences, and the University of British Columbia have found some women with early-stage, low-risk breast cancer may not need radiotherapy after breast conserving surgery.